论文信息 - A review of the totality of evidence in the development of ABP 798, a rituximab biosimilar. - 字舞流文

A review of the totality of evidence in the development of ABP 798, a rituximab biosimilar.

Stanley B. Cohen | D. Niederwieser | V. Hanes | Neungseon Seo | G. Burmester | C. Hamm | S. Lehto | P. Cobb | S. Cohen